Uncovering Drug Targets: Decoding Lipid-Protein Interactions

News   Mar 07, 2018 | Original story from Texas A&M University

 
Uncovering Drug Targets: Decoding Lipid-Protein Interactions

Membrane protein samples are infused into the mass spectrometry using nanoflow electrospray ionization (nESI). In this artwork, free and lipid bound membrane proteins are emerging from droplets in the nESI process prior to entering the mass spectrometer. Credit: Laganowsky Laboratory, Texas A&M University

 
 
 

RELATED ARTICLES

SpiderMass Device to Speed Up Cancer Surgery

News

A new proteomic assay called SpiderMass which heats water in human tissue to enable ion analysis will allow doctors to speed up cancer surgery by locating tumor biomarkers more quickly.

READ MORE

Antitumor Immune Function in Liver Controlled by Gut Microbiome

News

Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.

READ MORE

Tiny Particles Carry Tumor Shrinking Drugs into the Brain

News

MIT researchers have now devised a new drug-delivering nanoparticle that could offer a better way to treat glioblastoma. The particles, which carry two different drugs, are designed so that they can easily cross the blood-brain barrier and bind directly to tumor cells.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy